EVOLUTION Trials Testing Evobrutinib Now Recruiting

EVOLUTION Trials Testing Evobrutinib Now Recruiting

286891

EVOLUTION Trials Testing Evobrutinib Now Recruiting

Two global Phase 3 clinical trials testing the investigational oral medication evobrutinib are recruiting participants with relapsing forms of multiple sclerosis (MS). The two identically-designed trials — EVOLUTION RMS 1 (NCT04338022) and EVOLUTION RMS 2 (NCT04338061) — are specifically recruiting people with MS ages 18 to 55. Collectively, the trials intend to recruit 1,860 people with relapsing types of MS, specifically relapsing-remitting MS (RRMS) and active secondary progressive MS (SPMS). The trials are recruiting at locations…

You must be logged in to read/download the full post.